Pharmacy review rounds and medication appropriateness on a GEMU

Geriatrics Today: Journal of the Canadian Geriatrics Society

Volumn 8, Issue 1, 2005, Pages 21-26

  Jarrett, Pamela G ^a   Deschenes, Pamela J ^a   MacDonald, Elizabeth A ^a   Thompson, Caryn ^b  

^a Atlantic Health Sciences Corporation   (Canada)

^b UNIVERSITY OF NEW BRUNSWICK   (Canada)

Author keywords

Clinical Pharmacist; Geriatric Evaluation and Management Unit; Medication Appropriateness; Pharmacy Review

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARDIAC AGENT; CHOLINESTERASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DIURETIC AGENT; GASTROINTESTINAL AGENT; HYPNOTIC AGENT; MINERAL; MOOD STABILIZER; NARCOTIC AGENT; PARACETAMOL; VITAMIN;

ADULT; AGED; DRUG INDUCED DISEASE; EVALUATION; FEMALE; GERIATRIC CARE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MALE; NURSE; PHARMACIST; PHARMACY; PHYSICIAN; REVIEW;

EID: 20444411919     PISSN: 14963892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991;114:956-66.
2. Classen DC, Pestotnik SL, Evans RS et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs and attributable mortality. JAMA 1997;277:301-6.
3. Stewart RB, Cooper JW. Polypharmacy in the aged: practical solutions. Drugs & Aging 1994;4:449-61.
4. Hogan DB, Ebly EM, Fung TS. Regional variations in use of potentially inappropriate medications by Canadian seniors participating in the Canadian Study of Health and Aging. Can J Clin Pharmacol 1995;2:167-74.
5. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292-6.
6. Hanlon JT, Schmader KE, Samsa GP et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:1045-51.
7. Beers MH. Expli cit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997;157:1531-6.
8. Sloane PD, Gruber-Baldini AL, Zimmerman S et al. Medication undertreatment in assisted living settings. Arch Intern Med 2004;164:2031-7.
9. Avorn J. Polypharmacy A new paradigm for quality drug therapy in the elderly. Arch Intern Med 2004;164:1957-9.
10. Havranek EP, Abrams F, Stevens E et al. Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors. Arch Intern Med 1998;158:2024-8.
11. Berlowitz DR, Ash AS, Hickey EC et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957-63.
12. Giron MS, Wang HX, Bernsten C et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 2001;49:277-83.
13. Zhan C, Sangl J, Bierman AS et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001;286:2823-9.
14. Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001;161:1629-34.
15. Avorn J. Improving drug use in elderly patients: getting to the next level. JAMA 2001;286:2866-8.
16. Rubenstein LZ, Abrass IB, Kane RL. Improved care for patients on a new geriatric evaluation unit. J Am Geriatr Soc 1981;29:531-6.
17. Owens NJ, Sherburne NJ, Silliman RA et al. The Senior Care Study. The optimal use of medications in acutely ill older patients. J Am Geriatr Soc 1990;38:1082-7.
18. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
19. Kucukarslan SN, Peters M, Mlynarek M et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014-8.
20. Krska J, Cromarty JA, Arris F et al. Pharmacist - led medication review in patients over 65: a randomized, controlled trial in primary care. Age Aging 2001;30:205-11.
21. Sellors J, Kaczorowski J, Sellors C et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003;169:17-22.
22. Kennie NR, Sorensen TD. Assessment of drug-related problems in geriatric day hospital patients. Can J Hospital Pharm 1996;49:217-20.
23. Hanlon JT, Weinberger M, Samsa GP et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100:428-37.
24. Wong BJ, Vongenberg FR, Gilbert HD et al. Effectiveness of a pharmacist on a geriatric assessment team. P & T 1996;March:135-44.
25. Gill SS, Misiaszek BC, Brymer C. Improving prescribing in the elderly: a study in the long-term care setting. Can J Clin Pharmacol 2001;8:78-83.
26. Allard J, Hebert R, Rioux M et al. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ 2001;164:1291-6.
27. Nazareth I, Burton A, Shulman S et al. A pharmacy discharge plan for hospitalized elderly patients - a randomized controlled trial. Age Ageing 2001;30:33-40
28. Samsa GP, Hanlon JT, Schmader KE et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994;47:891-6.
29. Stolee P, Rockwood K, Fox RA et al. The use of goal attainment scaling in a geriatric care setting. J Am Geriatr Soc 1992;40:574-8.
30. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
31. McEvoy GK, ed. AHFS Drug Information 2003. Bethesda MD: American Society of Health-System Pharmacists, 2003.